Home
About Us
Inside Absci
Team
Our Values
Our Technology
Our Science
Posters
Manuscripts
Case Studies
All
Pipeline
Partner With Us
Investors
Careers
Life at Absci
Current Openings
Contact Us
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
Mar 27, 2025
Related Case Studies
Cracking HIV’s Code with AI-Designed Antibodies
ABS-101 Case Study: Potential best-in-class TL1A mAb for IBD
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
View More
Share this post
Related Resources
Cracking HIV’s Code with AI-Designed Antibodies
Read More
ABS-101 Case Study: Potential best-in-class TL1A mAb for IBD
Read More
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
Read More
Load More
